Diosmine in food supplements
84 supplements declared in France contain Diosmine as a substance or active ingredient.
Compl'Alim declarations. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
What we know about this ingredient
Uses
Calculated removal (%): 45.4
Consumption (g per capita) in France (2004): 6.18
Use (kg) in France (2004): 373544
Use classification
Cosmetics -> Antioxidant
A molecule found naturally in plants or organisms; in a supplement it may be extracted from them, made by fermentation or synthesised: the declaration does not say which.
Basis: one CosIngThe European Commission's database of cosmetic ingredients. CAS and natural occurrence recorded in Wikidata (LOTUS database).
Wikidata: names of substances in six languages and taxa in which they occur (largely from the LOTUS database), retrieved 23 October 2026.
Natural occurrence recorded in Wikidata (LOTUS database): 42 taxa; examples: Citrus paradisi, Citrus reticulata, Mentha piperita, Mentha spicata, Salvia officinalis.
Wikidata: names of substances in six languages and taxa in which they occur (largely from the LOTUS database), retrieved 23 October 2026.
Associated research
ClinicalTrials.gov · A trial is not proof: it tests a hypothesis.
- NCT07745426 : Clinical Study Comparing Diosmin vs Rebamipide as Adjuvant Therapies vs Conventional Therapy in Patients With Rheumatoid Arthritis
RECRUITING · PHASE2 · Rheumatoid Arthritis (RA) · 2026-08-04 · Diosmin
- NCT06256575 : Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis
RECRUITING · NA · Scleroderma, Systemic, Digital Ulcer · 2026-09-11 · Diosmin
2026-11-01
Other names: diosmin (English), Diosmin (German), diosmina (Spanish), diosmina (Italian), diosmina (Portuguese).
Wikidata: names of substances in six languages and taxa in which they occur (largely from the LOTUS database), retrieved 23 October 2026.
Same substance in cosmetics: DIOSMINE.
In plain words
À quoi il sert, selon les fabricants
Objectifs les plus souvent annoncés pour les compléments qui en contiennent (Diosmine) : circulation sanguine et lymphatique (47 produits), antioxydant (6 produits), détoxifiant / draineur (5 produits), artères et cholestérol (2 produits), digestion (1 produit).
Ce sont les objectifs déclarés par les fabricants à l'administration, pas des effets démontrés. Sur l'emballage, seules les allégations de santé autorisées par l'Union peuvent être écrites.
Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Nouvel aliment ou pas
Consommé avant le 15 mai 1997, mais seulement dans des compléments alimentaires : il peut y être utilisé ; dans un autre aliment, il lui faudrait une autorisation.
Le catalogue de la Commission est indicatif : il ne remplace pas une décision.
Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.
What the registers say, country by country
Each line repeats what an official register says on the date it was consulted. Not being in a register means neither allowed nor banned.
Novel food catalogue (European Union), entry “Diosmin”: Consommé avant le 15 mai 1997, mais seulement dans des compléments alimentaires : il peut y être utilisé ; dans un autre aliment, il lui faudrait une autorisation.
POL-NF-09901. Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.
Health claims register (European Union): 0 authorised and 1 refused claim(s) for this substance.
EU Register of nutrition and health claims, retrieved 21 October 2026.
Compl'Alim ingredient list (France): listed.
Compl'Alim, reference list of ingredients, retrieved 21 October 2026.
Canada, licensed natural health products (LNHPD): 2 products.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
United States, supplement labels (DSLD; supplements need no prior approval): 63 products.
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Declared daily quantities
| Unit | Products | Median | Minimum | Maximum |
|---|---|---|---|---|
| mg | 35 | 300 | 10 | 900 |
Calculated from Compl'Alim declarations that provide a quantity. These are quantities declared by manufacturers, not measurements, and preparation is not distinguished (powder, extract of varying concentration): differences between products can be very large.
Products
- VENOSID comprimé, declared in 2024
- VENOSTEN COMPRIMÉS LOGIDEX, comprimé, declared in 2025
- VENOUS CARE HSN, gélule, declared in 2025
- VINADIENCE 500 gélule, declared in 2020
- VS gélule, declared in 2022
- Varicaps Max gélule, declared in 2025
- Vein Support Doctor's BEST, capsule, declared in 2023
- VeinoMax gélule, declared in 2024
- Venaflux Complex Vegavero, capsule, declared in 2022
- Veniseptico capsule, declared in 2023
- Venodren Vimpharma, comprimé, declared in 2026
- Venotur Jambes fatiguées (30 comprimés) Novonatur, comprimé, declared in 2025
- Vitastrong DIOSMIN PRO comprimé, declared in 2025
- YAMAMOTO RESEARCH - MICROCIRCOLO comprimé, declared in 2019
- YAMAMOTO RESEARCH - VASOMIL sachet, flavour fruits rouges, declared in 2022
- ACTIVEIN PRESCRIPTION NATURE, gélule, withdrawn from the market
- ACTIVEIN gélule, withdrawn from the market
- CIRCULATION LABORATOIRE GIPHAR, gélule, withdrawn from the market
- Circulymphamix NATURAMedicatrix, gélule, withdrawn from the market
- DIOSMIN COMPLEX HSN, capsule, withdrawn from the market
- DIOSMINE 1.9 Trenker, comprimé, withdrawn from the market
- JAMBES LÉGÈRES MEDILAB, gélule, withdrawn from the market
- RUTINE 750 Diosmine Hespéridine Nature Attitude, gélule, withdrawn from the market
- VNOSID comprimé, withdrawn from the market